Back to Home Page
 
 

Professor Ariane DeAgostini, University of Geneva Medical School, Geneva, Switzerland - Folicular fluid glycosaminogylcans.


Professor Jon Amster, University of Georgia, Athens, GA — FT-ICR MS for the determination of glycosaminoglycan structure.


Professor Jesus Jimenez Barbero, Istituto de Quìmica Orgánica, CSIC, Madrid, Spain Conformation of Neuraminic Acid C-glycosides.


Professor Thomas Baumert and Michael Nassal University of Frieburg, Germany Hepatitis C and Glycosaminoglycans
   

<>

Professor Mirek Cygler, Biotechnology Research Institute, Montreal, Canada Xray Cocrystallization of Polysaccharide Lyases with Oligosaccharides.


Professor Paul DeAngelis, University of Oklahoma Health Sciences Center, Oklahoma City, OK Microbial Enzymes in the Synthesis of Glycosaminoglycans.


Professor Jonathan Dordick, Rensselaer Polytechnic Institute, Troy, NY Enzymes in RTILs and on nano structures.




Professor Jawed Fareed, Loyola University, Illinois Anticoagulant Activity and Bioavailablity of Heparinoids.




Professor Hari Garg, Harvard Medical School, Massachusetts Glycosaminoglycans and Angiogenesis.


Professor Linda Hiebert, University of Saskatchewan, Saskatoon, Canada Oral Bioavailability of Heparin.



Professor Dena Howland, University of Florida, Gainsville, FL - Chondroitinase for the treatment of spinal cord injury.



Professor Dennis Kasper, Harvard University Medical School, Boston, MA   MHCII pathway and the generation of IgG antibodies against heparin and related polysaccharides.




Professor Patrick Page-McCaw, RPI Department of Biology - Angiogenesis and vasculargensis in zebrafish.



Professor Yeong-Shik Kim, Seoul National University, South Korea Isolation of GAGs Having Novel Structures.




Professor Jian Liu, University of North Carolina, Chapel Hill, NC Biosynthetic Enzymes and Glycosaminoglycans.



Professor Shaker Mousa, Albany College of Pharmacy, Albany, NY Heparin and Thromosis and Hemostasis and Angiogenesis.


Professor Miriam Barrow, Harvard University Medical School - Interaction of ACP bacterial protein with heparin/HS.


Professor Scott McCallum, Biotechnology Center, RPI, Troy, NY - VEGF - Synthetic heparin interactions.



Professor Moosa Mohammadi, NYU, New York — FGF-FGFR-Heparin Interactions.


 

Professor Michael Pierce, CCRC, University of Georgia, Athens, GA — Glycomics of heparan sulfate in stem cell differenliation.




Professor Kelley Moremen, Alison Nairn
, and Steve Dalton
, CCRC and University of Georgia, Athens, GA - Glycomics of heparan sulfate in stem cell


Professor Susan Sharfstein, Rensselaer Polytechnic Institute, Troy, NY Engineering of Glycans.


Professor Photini Sinnis, NYU, NYC, NY — Role of heparan sulfate in malaria.


Professor Toshihiko Toida, Chiba University, Japan Preparation and analysis of oligosaccharides.


Professor Jeremy Turnbull, University of Birmingham, U.K. — Sequencing Heparin Oligosaccharides.



Professor Brian Volkman, Medical College of Wisconsin, Milwaukee NMR of Heparin Interaction with Lymphotactin and PSP-1.




Dr. Joanne K. Tobacman, University of Illinois, Chicago — Carrageenan related physiology.




Professor Preeyanat Vongchan, Chiang Mai University, Thailand - HSPG related antibodies and immunology.




Professor Steven R. Van Doren, University of Missouri, Columbia - GAG-protein (pro-matrilysin, MMP-7) interactions.




Professor Pulickel Ajayan, Rice University — Nanoscience.




Professor George Drusano, Ordway, Albany Anti-influenza agents.





Back to Home Page